XG7-13413-23483 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-04-14
Dose 1 — Pfizer-BioNTech
2021-04-19
Registered in v-safe
2021-04-19
Survey response — days 1–6 daily, dose 1
MedDRA: Vision blurred — Feeling: Good

Free text: Blurry vision

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-20
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-04-21
Health check-in — day 7, dose 1
Feeling: Good · None

Adult check-in
2021-04-28
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-05-05
Dose 2 — Pfizer-BioNTech
2021-05-05
Health check-in — day 0, dose 2
Feeling: Good · None

Adult check-in
2021-05-06
Health check-in — days 1–6 daily, dose 2
Feeling: Poor · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities

Adult check-in
2021-05-08
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-05-09
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-05-10
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-05-11
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-05-12
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2021-05-19
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-05-27
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-06-02
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-06-09
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-06-16
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-08-04
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-11-03
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2021-12-07
Dose 3 — Pfizer-BioNTech
2022-06-09
Health check-in — 6 months, dose 3
Feeling: Good

Adult check-in
2022-09-29
Dose 4 — Pfizer-BioNTech
2022-10-08
Health check-in — day 7, dose 4
Feeling: Good · None

Adult check-in
2022-10-13
Health check-in — day 14, dose 4
Feeling: Good

Adult check-in
2022-10-20
Survey response — day 21, dose 4
MedDRA: HELLP syndrome — Feeling: Good · Get care from a doctor or other healthcare professional · Hospitalization

Free text: HELLP Syndrome

MedDRA releases: 2024-11 · check-in free text available
2022-10-20
Report sent to call center — day 21, dose 4
Get care from a doctor or other healthcare professional

Hospitalization · 1 call case(s)
2022-10-21
Call 1 — Left Voicemail
2022-10-27
Health check-in — day 28, dose 4
Feeling: Good

Adult check-in
2022-11-10
Health check-in — day 42, dose 4
Feeling: Good

Adult check-in
2022-12-29
Health check-in — 3 months, dose 4
Feeling: Good

Adult check-in
2023-03-30
Health check-in — 6 months, dose 4
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-04-14	Pfizer-BioNTech
2	2021-05-05	Pfizer-BioNTech
3	2021-12-07	Pfizer-BioNTech	No
4	2022-09-29	Pfizer-BioNTech	No

Call center

Reported	Outcome	VAERS-related outcome
2022-10-20	Unsuccessful

Free text

Release 7 — days 1–6 daily, dose 1

2021-04-19

Systemic reaction (other): Blurry vision

Release 12 — day 21, dose 4

2022-10-20

Symptoms: HELLP Syndrome

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	HELLP syndrome	·	·	✓
SRO	Vision blurred	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release